BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 3018476)

  • 1. Receptor reserve in the calcium-dependent cyclic AMP response of astrocytoma cells to muscarinic receptor stimulation: demonstration by agonist-induced desensitization, receptor inactivation, and phorbol ester treatment.
    Harden TK; Heng MM; Brown JH
    Mol Pharmacol; 1986 Sep; 30(3):200-6. PubMed ID: 3018476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscarinic cholinergic receptor-mediated control of cyclic AMP metabolism. Agonist-induced changes in nucleotide synthesis and degradation.
    Meeker RB; Harden TK
    Mol Pharmacol; 1983 Mar; 23(2):384-92. PubMed ID: 6300648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscarinic cholinergic receptors of two cell lines that regulate cyclic AMP metabolism by different molecular mechanisms.
    Evans T; Smith MM; Tanner LI; Harden TK
    Mol Pharmacol; 1984 Nov; 26(3):395-404. PubMed ID: 6092892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in muscarinic receptor reserve for inhibition of adenylate cyclase and stimulation of phosphoinositide hydrolysis in chick heart cells.
    Brown JH; Goldstein D
    Mol Pharmacol; 1986 Dec; 30(6):566-70. PubMed ID: 3023810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the phosphodiesterase regulated by muscarinic cholinergic receptors of 1321N1 human astrocytoma cells.
    Tanner LI; Harden TK; Wells JN; Martin MW
    Mol Pharmacol; 1986 May; 29(5):455-60. PubMed ID: 2422535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agonist-induced desensitization of muscarinic receptor-mediated calcium efflux without concomitant desensitization of phosphoinositide hydrolysis.
    Masters SB; Quinn MT; Brown JH
    Mol Pharmacol; 1985 Mar; 27(3):325-32. PubMed ID: 2983182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of cyclic AMP metabolism by muscarinic cholinergic receptors.
    Harden TK; Evans T; Hepler JR; Hughes AR; Martin MW; Meeker RB; Smith MM; Tanner LI
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1985; 19():207-20. PubMed ID: 2988297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of agonists with M2 and M4 muscarinic receptor subtypes mediating cyclic AMP inhibition.
    McKinney M; Miller JH; Gibson VA; Nickelson L; Aksoy S
    Mol Pharmacol; 1991 Dec; 40(6):1014-22. PubMed ID: 1722002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual effects of muscarinic M(2) acetylcholine receptors on the synthesis of cyclic AMP in CHO cells: dependence on time, receptor density and receptor agonists.
    Michal P; Lysíková M; Tucek S
    Br J Pharmacol; 2001 Mar; 132(6):1217-28. PubMed ID: 11250872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase C activators sensitize cyclic AMP accumulation by intact 1321N1 human astrocytoma cells.
    Johnson RA; Toews ML
    Mol Pharmacol; 1990 Feb; 37(2):296-303. PubMed ID: 1689454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic AMP potentiates receptor-stimulated phosphoinositide hydrolysis in human neuroepithelioma cells.
    Fisher SK; McEwen EL; Lovell SC; Landon RE
    Mol Pharmacol; 1992 Aug; 42(2):340-6. PubMed ID: 1355263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Mediation of separate responses by high affinity and low affinity agonist-receptor conformations.
    McKinney M; Stenstrom S; Richelson E
    Mol Pharmacol; 1985 Feb; 27(2):223-35. PubMed ID: 2982089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H1-histamine receptors on human astrocytoma cells.
    Nakahata N; Martin MW; Hughes AR; Hepler JR; Harden TK
    Mol Pharmacol; 1986 Feb; 29(2):188-95. PubMed ID: 2419744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscarinic m2 receptors in cerebellar granule cell cultures from rat: mechanism of short-term desensitization.
    Contrera JG; Mcleskey SW; Holopainen I; Xu J; Wojcik WJ
    J Pharmacol Exp Ther; 1993 Apr; 265(1):433-40. PubMed ID: 8474025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships between phosphoinositide and calcium responses to muscarinic agonists in astrocytoma cells.
    Masters SB; Harden TK; Brown JH
    Mol Pharmacol; 1984 Sep; 26(2):149-55. PubMed ID: 6090879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscarinic receptor-mediated translocation of calmodulin in SK-N-SH human neuroblastoma cells.
    Mangels LA; Gnegy ME
    Mol Pharmacol; 1990 Jun; 37(6):820-6. PubMed ID: 2359403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscarinic cholinergic receptors on cultured thyroid cells. I. Biological effect of carbachol and characterization of the receptors.
    Champion S; Mauchamp J
    Mol Pharmacol; 1982 Jan; 21(1):66-72. PubMed ID: 6290866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandins and muscarinic agonists induce cyclic AMP attenuation by two distinct mechanisms in the pregnant-rat myometrium. Interaction between cyclic AMP and Ca2+ signals.
    Goureau O; Tanfin Z; Harbon S
    Biochem J; 1990 Nov; 271(3):667-73. PubMed ID: 1700899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The putative M1 muscarinic receptor does not regulate phosphoinositide hydrolysis. Studies with pirenzepine and McN-A343 in chick heart and astrocytoma cells.
    Brown JH; Goldstein D; Masters SB
    Mol Pharmacol; 1985 May; 27(5):525-31. PubMed ID: 2581122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of spasmogen-stimulated Ins(1,4,5)P3 generation and functional responses by selective inhibitors of types 3 and 4 phosphodiesterase in airways smooth muscle.
    Challiss RA; Adams D; Mistry R; Nicholson CD
    Br J Pharmacol; 1998 May; 124(1):47-54. PubMed ID: 9630342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.